Paper Details

  1. Home
  2. Paper Details

Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.

Author: ChatterjeeAnjan, DruytsEric, GoadsbyPeter J, MillsEdward J, RamosElodie, ThorlundKristian, WuPing

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Migraine is a common headache disorder. Triptans, a type of medication, are effective in stopping migraine attacks, reducing pain, and improving quality of life. While there have been some comparisons between different triptans, research on all possible combinations is limited. This information would be helpful for doctors to make the best treatment choices.
Paper Details　
Original Abstract of the Article :
Migraine is the most common neurological condition in developed countries. The abortive treatment of migraine attacks is important both for quality of life and costs associated with illness. Triptans, serotonin 5-HT1B/1D receptor agonists, effectively relieve the pain, disability, and associated sym...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/0333102413508661

データ提供：米国国立医学図書館（NLM）

Triptans: A Comparative Analysis of Migraine Treatment

Migraines are a common neurological condition, affecting millions worldwide. This research dives into the [treatment of migraine], specifically focusing on the efficacy of [triptans], a class of drugs that target [serotonin receptors]. The authors conducted a [meta-analysis] of existing studies comparing different [triptans] for the [abortive treatment] of [migraine]. Their findings provide valuable insights into the [relative effectiveness] of various [triptans] in managing [migraine attacks]. The researchers identified [specific triptans] that were consistently more effective in reducing [migraine pain, disability, and associated symptoms]. This information is particularly useful for clinicians who need to choose the most appropriate [triptan] for their patients.

Triptans: A Powerful Weapon Against Migraines

This research reveals that [triptans] are a valuable tool in the fight against [migraine], offering relief from [pain, disability, and other symptoms]. The findings suggest that certain [triptans] may be more effective than others, providing clinicians with a roadmap to personalize treatment. The [meta-analysis] highlights the importance of considering [individual patient characteristics] when choosing a [triptan] for migraine management.

Navigating Migraine Management: A Patient's Guide

If you struggle with [migraines], this research provides valuable insights into the [treatment options] available. Understanding the different [triptans] and their relative effectiveness can empower you to make informed decisions about your care. It's important to discuss your [migraine] symptoms and treatment options with your doctor to determine the best course of action for you.

Dr.Camel's Conclusion

The researchers have done a great job in clarifying the effectiveness of different [triptans] in treating [migraines]. This information is essential for patients and doctors alike, as it provides a roadmap for choosing the most effective treatment. Just as a camel relies on its strong legs to traverse the desert, migraine sufferers can find relief and improve their quality of life with the help of [triptans].

Date :
  1. Date Completed 2014-11-14
  2. Date Revised 2022-03-11
Further Info :

Pubmed ID

24108308

DOI: Digital Object Identifier

10.1177/0333102413508661

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.